PET scans may allow early prediction of response to targeted therapy of thyroid cancer
Reston, Va. (February 1, 2011) — Positron emission tomography (PET) can image metabolic changes following treatment with the protein kinase inhibitor vandetanib, helping to define the therapy response or the effectiveness of the therapeutic agent…